Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada flag Canada · Delayed Price · Currency is CAD
0.1000
0.00 (0.00%)
Jul 21, 2025, 3:00 PM EDT

Pharmala Biotech Holdings Revenue

Pharmala Biotech Holdings had revenue of 145.66K CAD in the quarter ending February 28, 2025, with 161.97% growth. This brings the company's revenue in the last twelve months to 430.18K, down -65.50% year-over-year. In the fiscal year ending August 31, 2024, Pharmala Biotech Holdings had annual revenue of 1.04M with 94.60% growth.

Revenue (ttm)
430.18K
Revenue Growth
-65.50%
P/S Ratio
24.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.52M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Aug 31, 20241.04M503.29K94.60%
Aug 31, 2023532.00K453.93K581.44%
Aug 31, 202278.07K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition